COVID-19 in young and middle aged adults. Predictors of poor evolution and clinical differences.
E. Tabernero Huguet (Bizkaia, Spain), L. Ruiz Iturriaga (Bizkaia, Spain), L. Serrano Fernandez (Bizkaia, Spain), P. España Yandiola (Bizkaia, Spain), R. Mendez (Valencia, Spain), B. Santos Zorrozua (Bizkaia, Spain), A. Uranga Echeverria (Bizkaia, Spain), P. Gonzalez Jimenez (Valencia, Spain), P. Garcia Hontoria (Bizkaia, Spain), R. Menendez Villanueva (Valencia, Spain), R. Zalacain Jorge (Bizkaia, Spain)
Source: Virtual Congress 2021 – Chronic COVID - 19
Session: Chronic COVID - 19
Session type: Oral Presentation
Number: 88
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Tabernero Huguet (Bizkaia, Spain), L. Ruiz Iturriaga (Bizkaia, Spain), L. Serrano Fernandez (Bizkaia, Spain), P. España Yandiola (Bizkaia, Spain), R. Mendez (Valencia, Spain), B. Santos Zorrozua (Bizkaia, Spain), A. Uranga Echeverria (Bizkaia, Spain), P. Gonzalez Jimenez (Valencia, Spain), P. Garcia Hontoria (Bizkaia, Spain), R. Menendez Villanueva (Valencia, Spain), R. Zalacain Jorge (Bizkaia, Spain). COVID-19 in young and middle aged adults. Predictors of poor evolution and clinical differences.. 88
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: